Cargando…

Antidiabetic and antihyperlipidemic effects of Argyreia pierreana and Matelea denticulata: Higher activity of the micellar nanoformulation over the crude extract

BACKGROUND AND AIM: Herbal medicine combined with nanotechnology is widely proposed to improve the oral bioavailability, reduce the required dose and side effects, and improve the pharmacological efficacy of extracts. Thus, this study evaluated the in vivo antidiabetic and antihyperlipidemic activit...

Descripción completa

Detalles Bibliográficos
Autores principales: Gudise, Venkataiah, Chowdhury, Bimalendu, Manjappa, Arehalli S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8116714/
https://www.ncbi.nlm.nih.gov/pubmed/34012872
http://dx.doi.org/10.1016/j.jtcme.2020.08.001
_version_ 1783691454017699840
author Gudise, Venkataiah
Chowdhury, Bimalendu
Manjappa, Arehalli S.
author_facet Gudise, Venkataiah
Chowdhury, Bimalendu
Manjappa, Arehalli S.
author_sort Gudise, Venkataiah
collection PubMed
description BACKGROUND AND AIM: Herbal medicine combined with nanotechnology is widely proposed to improve the oral bioavailability, reduce the required dose and side effects, and improve the pharmacological efficacy of extracts. Thus, this study evaluated the in vivo antidiabetic and antihyperlipidemic activities of ethanolic leaf extracts of Argyreia pierreana (AP) and Matelea denticulata (MP) plants in comparison with their micellar nanoformulations. MATERIALS AND METHODS: The mixed micelles (MMs) loaded with crude extracts (CEs) of AP and MD (AP-MMs and MD-MMs) were prepared using a film dispersion technique. Type 2 diabetes was induced in rats using high-fat diet (HFD) and low-dose (35 mg/kg) streptozotocin (STZ) injection. The pharmacological actions of CEs, AP-MMs and MD-MMs were determined in type 2 diabetic Sprague-Dawley rats. RESULTS: Oral treatments with low-dose AP-MMs and MD-MMs having a mean particle size of 163 ± 10 nm and 145 ± 8 nm respectively, resulted in significantly decreased fasting blood glucose level and increased serum insulin, glucokinase levels, and normalized the elevated levels of hemoglobin A1C and glucose-6-phosphatase. Both extracts significantly decreased serum total cholesterol, triglycerides, and low-density lipoprotein, as well as elevated high-density lipoprotein levels. Additionally, improvements in antioxidant enzymes (superoxide dismutase, catalase, glutathione peroxidase) and malondialdehyde levels were evidenced clearly in tested vital organs (brain, heart, liver). CONCLUSION: This is the first report of the antidiabetic and antihyperlipidemic activities of ethanolic leaf extracts of AP and MP plants. Our findings indicate the potential utility of nanotechnology in improving the oral therapeutic efficacy of herbal extracts.
format Online
Article
Text
id pubmed-8116714
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-81167142021-05-18 Antidiabetic and antihyperlipidemic effects of Argyreia pierreana and Matelea denticulata: Higher activity of the micellar nanoformulation over the crude extract Gudise, Venkataiah Chowdhury, Bimalendu Manjappa, Arehalli S. J Tradit Complement Med Original Article BACKGROUND AND AIM: Herbal medicine combined with nanotechnology is widely proposed to improve the oral bioavailability, reduce the required dose and side effects, and improve the pharmacological efficacy of extracts. Thus, this study evaluated the in vivo antidiabetic and antihyperlipidemic activities of ethanolic leaf extracts of Argyreia pierreana (AP) and Matelea denticulata (MP) plants in comparison with their micellar nanoformulations. MATERIALS AND METHODS: The mixed micelles (MMs) loaded with crude extracts (CEs) of AP and MD (AP-MMs and MD-MMs) were prepared using a film dispersion technique. Type 2 diabetes was induced in rats using high-fat diet (HFD) and low-dose (35 mg/kg) streptozotocin (STZ) injection. The pharmacological actions of CEs, AP-MMs and MD-MMs were determined in type 2 diabetic Sprague-Dawley rats. RESULTS: Oral treatments with low-dose AP-MMs and MD-MMs having a mean particle size of 163 ± 10 nm and 145 ± 8 nm respectively, resulted in significantly decreased fasting blood glucose level and increased serum insulin, glucokinase levels, and normalized the elevated levels of hemoglobin A1C and glucose-6-phosphatase. Both extracts significantly decreased serum total cholesterol, triglycerides, and low-density lipoprotein, as well as elevated high-density lipoprotein levels. Additionally, improvements in antioxidant enzymes (superoxide dismutase, catalase, glutathione peroxidase) and malondialdehyde levels were evidenced clearly in tested vital organs (brain, heart, liver). CONCLUSION: This is the first report of the antidiabetic and antihyperlipidemic activities of ethanolic leaf extracts of AP and MP plants. Our findings indicate the potential utility of nanotechnology in improving the oral therapeutic efficacy of herbal extracts. Elsevier 2020-08-06 /pmc/articles/PMC8116714/ /pubmed/34012872 http://dx.doi.org/10.1016/j.jtcme.2020.08.001 Text en © 2020 Center for Food and Biomolecules, National Taiwan University. Production and hosting by Elsevier Taiwan LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Article
Gudise, Venkataiah
Chowdhury, Bimalendu
Manjappa, Arehalli S.
Antidiabetic and antihyperlipidemic effects of Argyreia pierreana and Matelea denticulata: Higher activity of the micellar nanoformulation over the crude extract
title Antidiabetic and antihyperlipidemic effects of Argyreia pierreana and Matelea denticulata: Higher activity of the micellar nanoformulation over the crude extract
title_full Antidiabetic and antihyperlipidemic effects of Argyreia pierreana and Matelea denticulata: Higher activity of the micellar nanoformulation over the crude extract
title_fullStr Antidiabetic and antihyperlipidemic effects of Argyreia pierreana and Matelea denticulata: Higher activity of the micellar nanoformulation over the crude extract
title_full_unstemmed Antidiabetic and antihyperlipidemic effects of Argyreia pierreana and Matelea denticulata: Higher activity of the micellar nanoformulation over the crude extract
title_short Antidiabetic and antihyperlipidemic effects of Argyreia pierreana and Matelea denticulata: Higher activity of the micellar nanoformulation over the crude extract
title_sort antidiabetic and antihyperlipidemic effects of argyreia pierreana and matelea denticulata: higher activity of the micellar nanoformulation over the crude extract
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8116714/
https://www.ncbi.nlm.nih.gov/pubmed/34012872
http://dx.doi.org/10.1016/j.jtcme.2020.08.001
work_keys_str_mv AT gudisevenkataiah antidiabeticandantihyperlipidemiceffectsofargyreiapierreanaandmateleadenticulatahigheractivityofthemicellarnanoformulationoverthecrudeextract
AT chowdhurybimalendu antidiabeticandantihyperlipidemiceffectsofargyreiapierreanaandmateleadenticulatahigheractivityofthemicellarnanoformulationoverthecrudeextract
AT manjappaarehallis antidiabeticandantihyperlipidemiceffectsofargyreiapierreanaandmateleadenticulatahigheractivityofthemicellarnanoformulationoverthecrudeextract